Abiopharma

🔍 Kim Paul (Executive)

Company: Fulgent Genetics, Inc. (FLGT)

Report Date: 2025-08-23

Detailed Transactions and Holdings:

• Sold 670 shares of Common Stock at $21.77 per share (Direct)
  Date: 2025-08-23 | Code: F | equity_swap_involved: false | shares_owned_after: 339,158.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.